NDA 077701 describes CIPROFLOXACIN EXTENDED RELEASE, which is a drug marketed by
Ani Pharms,
Dr Reddys Labs Ltd,
Fosun Pharma,
Ph Health, and
Rising, and is included in five NDAs. Additional details are available on the
CIPROFLOXACIN EXTENDED RELEASE profile page.
The generic ingredient in CIPROFLOXACIN EXTENDED RELEASE is
ciprofloxacin; ciprofloxacin hydrochloride. There is one
drug master file entry for this compound. Additional details are available on the
ciprofloxacin; ciprofloxacin hydrochloride profile page.